Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Goldberg Mark Alan

SEC-identified person · CIK 1532475 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Blueprint Medicines Corp BPMC Director filed 2015–2025
Glycomimetics INC GLYC Director filed 2014–2024
Immunogen, Inc. IMGN Director filed 2011–2024
Idera Pharmaceuticals, INC. IDRA Director filed 2014–2022
Audentes Therapeutics, Inc. BOLD Director filed 2017–2020
Atyr Pharma INC LIFE Director filed 2015–2017
Trimeris INC TRMS Director · SVP,Medical&Regulatory Affairs filed 2011–2014

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.